Sovereignty, equity, solidarity: progress on the Global Health Emergency Corps.
Dowell SF. et al, (2025), BMJ global health, 10
PEARLES challenges and solutions to the implementation of clinical research responses to epidemics and pandemics: a scoping review
Crealock-Ashurst B. et al, (2025), eClinicalMedicine, 85, 103294 - 103294
International collaboration to advance research preparedness and response
Rojek A. and Carson G., (2024), Principles and Practice of Emergency Research Response, 765 - 777
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Roper KJ. et al, (2023), Scientific Reports, 13
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.
Shah N. et al, (2023), Artificial organs, 47, 1490 - 1502
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Strategizing Across Organizations
Ramirez R. et al, (2023), MIT SLOAN MANAGEMENT REVIEW, 64, 62 - 65
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
Characterising Long Covid: a living systematic review update with controlled studies
Michelen M. et al, (2022)
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 715 - 724
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Knight SR. et al, (2022), Thorax, 77, 606 - 615
What comes next in the COVID-19 pandemic?
Fisher D. et al, (2022), Lancet (London, England), 399, 1691 - 1692
Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.
Millar JE. et al, (2022), Scientific reports, 12
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Osmanov IM. et al, (2022), European Respiratory Journal, 59, 2101341 - 2101341
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Research priorities for Long Covid: refined through an international multi-stakeholder forum
Carson G., (2021), BMC Medicine, 19
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall MD. et al, (2021), eLife, 10
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Evans RA. et al, (2021), The Lancet Respiratory Medicine, 9, 1275 - 1287
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
de Silva TI. et al, (2021), iScience, 24, 103353 - 103353
A prenylated dsRNA sensor protects against severe COVID-19
Wickenhagen A. et al, (2021), Science, 374
Are medical procedures that induce coughing or involve respiratory suctioning associated with increased generation of aerosols and risk of SARS-CoV-2 infection? A rapid systematic review.
Wilson J. et al, (2021), The Journal of hospital infection, 116, 37 - 46
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Abdukahil SA. et al, (2021), Infection, 49, 889 - 905
Characterising long COVID: a living systematic review
Michelen M. et al, (2021), BMJ Global Health, 6, e005427 - e005427
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Munblit D. et al, (2021), Clinical & Experimental Allergy, 51, 1107 - 1120
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Sigfrid L. et al, (2021), The Lancet Regional Health - Europe, 8, 100186 - 100186
What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
Michelen M. et al, (2021), F1000Research, 9, 1455 - 1455
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Russell CD. et al, (2021), The Lancet Microbe, 2, e354 - e365
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Drake TM. et al, (2021), The Lancet, 398, 223 - 237
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort
Yates T. et al, (2021), Obesity, 29, 1223 - 1230
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Bloom CI. et al, (2021), The Lancet Respiratory Medicine, 9, 699 - 711
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review
Manoharan L. et al, (2021), PLOS ONE, 16, e0251250 - e0251250
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
Norton A. et al, (2021), The Lancet Infectious Diseases, 21, 601 - 602
Priorities for COVID-19 research response and preparedness in low-resource settings
Norton AJ. et al, (2021), The Lancet, 397, 1866 - 1868
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
Sigfrid L. et al, (2021), BMJ Open, 11, e043887 - e043887
Prevalence of Asymptomatic SARS-CoV-2 Infection.
Cevik M. et al, (2021), Annals of internal medicine, 174, 283 - 284
A living mapping review for COVID-19 funded research projects: three-month update
Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209
Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review
Sigfrid L. et al, (2020), BMC Medicine, 18
Key clinical research questions asked during epidemic respiratory outbreaks: A systematic review
Harris C. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 267 - 267